Showing results (61-70 of 1,434) with videos related to

Sort By:
Pageof 144
Bone Marrow Transplantation|August 11, 2001
Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteriaB Sirohi, R Powles, S Kulkarni, et al.
British Journal of Cancer|August 7, 2001
Glomerular filtration rate prior to high-dose melphalan 200 mg/m(2) as a surrogate marker of outcome in patients with myelomaB Sirohi, R Powles, S Kulkarni, et al.
Bone Marrow Transplantation|March 14, 2000
The role of autologous transplantation in patients with multiple myeloma aged 65 years and overB Sirohi, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|November 20, 2002
Reassessing the definition of myeloid engraftment after autotransplantation: it is not necessary to see 0.5 x 10(9)/l neutrophils on 3 consecutive days to define myeloid recoveryM Y Ali, Y Oyama, J Monreal, et al.
Bone Marrow Transplantation|January 27, 2004
How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients?A Verma, J Pedicano, S Trifilio, et al.
Bone Marrow Transplantation|June 26, 2007
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazoleS Trifilio, S Singhal, S Williams, et al.
Bone Marrow Transplantation|July 1, 1997
Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignanciesJ Mehta, S Kelsey, P Chu, et al.
Bone Marrow Transplantation|April 15, 2008
The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patientsB Sirohi, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|August 6, 1999
Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapyS Singhal, J Mehta, K Desikan, et al.
Bone Marrow Transplantation|May 19, 2006
Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemiaS Trifilio, L Gordon, S Singhal, et al.
Pageof 144